Novonesis A/S Class BNovonesis A/S Class BNovonesis A/S Class B

Novonesis A/S Class B

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪24.90 B‬EUR
‪304.94 M‬EUR
‪3.82 B‬EUR
‪343.94 M‬
Beta (1Y)
0.17
Employees (FY)
‪10.58 K‬
Change (1Y)
‪+3.83 K‬ +56.63%
Revenue / Employee (1Y)
‪361.24 K‬EUR
Net income / Employee (1Y)
‪28.82 K‬EUR

About Novonesis A/S Class B


CEO
Ester Baiget
Headquarters
Lyngby
ISIN
DK0060336014
FIGI
BBG00KDZJQK3
Novonesis (Novozymes A/S) engages in the era of biosolutions. It innovate and develop transformative biosolutions that improve the way the world produces, consumes, and lives. The company was founded on January 29, 2024 is headquartered in Lyngby, Denmark.

Check out other big names from the same industry as NZYM.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
VXUS
Vanguard Total International Stock ETF
Weight
0.05%
Market value
‪301.43 M‬
USD
VEA
Vanguard FTSE Developed Markets ETF
Weight
0.07%
Market value
‪193.93 M‬
USD
IEFA
iShares Core MSCI EAFE ETF
Weight
0.10%
Market value
‪149.45 M‬
USD
EFA
iShares MSCI EAFE ETF
Weight
0.11%
Market value
‪74.39 M‬
USD
XACTC25
XACT OMXC25 ESG (UCITS ETF)
Weight
8.10%
Market value
‪61.21 M‬
USD
VGK
Vanguard FTSE Europe ETF
Weight
0.14%
Market value
‪51.21 M‬
USD
SCHF
Schwab International Equity ETF
Weight
0.09%
Market value
‪45.82 M‬
USD
VEU
Vanguard FTSE All-World ex-US Index Fund
Weight
0.06%
Market value
‪45.03 M‬
USD
DFIV
Dimensional International Value ETF
Weight
0.30%
Market value
‪42.79 M‬
USD
JIRE
JPMorgan International Research Enhanced Equity ETF
Weight
0.41%
Market value
‪36.93 M‬
USD
ADEF
Apostle Dundas Global Equity Fund Units Class D
Weight
1.89%
Market value
‪33.66 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of NZYM is 53.40 EUR — it has decreased by −0.45% in the past 24 hours. Watch Novonesis A/S Class B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange Novonesis A/S Class B stocks are traded under the ticker NZYM.
NZYM stock has fallen by −6.01% compared to the previous week, the month change is a −2.84% fall, over the last year Novonesis A/S Class B has showed a 2.22% increase.
We've gathered analysts' opinions on Novonesis A/S Class B future price: according to them, NZYM price has a max estimate of 76.23 EUR and a min estimate of 50.89 EUR. Watch NZYM chart and read a more detailed Novonesis A/S Class B stock forecast: see what analysts think of Novonesis A/S Class B and suggest that you do with its stocks.
NZYM reached its all-time high on Jan 3, 2022 with the price of 72.76 EUR, and its all-time low was 35.86 EUR and was reached on Jan 25, 2019. View more price dynamics on NZYM chart.
See other stocks reaching their highest and lowest prices.
NZYM stock is 0.67% volatile and has beta coefficient of 0.17. Track Novonesis A/S Class B stock price on the chart and check out the list of the most volatile stocks — is Novonesis A/S Class B there?
Today Novonesis A/S Class B has the market capitalization of ‪24.90 B‬, it has increased by 1.66% over the last week.
Yes, you can track Novonesis A/S Class B financials in yearly and quarterly reports right on TradingView.
Novonesis A/S Class B is going to release the next earnings report on Feb 25, 2026. Keep track of upcoming events with our Earnings Calendar.
NZYM earnings for the last quarter are 0.41 EUR per share, whereas the estimation was 0.41 EUR resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.76 EUR per share. See more details about Novonesis A/S Class B earnings.
Novonesis A/S Class B revenue for the last quarter amounts to ‪1.06 B‬ EUR, despite the estimated figure of ‪1.06 B‬ EUR. In the next quarter, revenue is expected to reach ‪1.03 B‬ EUR.
NZYM net income for the last quarter is ‪137.63 M‬ EUR, while the quarter before that showed ‪136.50 M‬ EUR of net income which accounts for 0.82% change. Track more Novonesis A/S Class B financial stats to get the full picture.
Novonesis A/S Class B dividend yield was 1.52% in 2024, and payout ratio reached 124.39%. The year before the numbers were 1.67% and 56.80% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 20, 2025, the company has ‪10.58 K‬ employees. See our rating of the largest employees — is Novonesis A/S Class B on this list?
Like other stocks, NZYM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Novonesis A/S Class B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Novonesis A/S Class B technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Novonesis A/S Class B stock shows the sell signal. See more of Novonesis A/S Class B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.